Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

GLOBAL HEALTH LTD.

NSE : MEDANTABSE : 543654ISIN CODE : INE474Q01031Industry : Hospital & Healthcare ServicesHouse : Private

BSE1001.0511 (+1.11 %)

PREV CLOSE ( ) 990.05

OPEN PRICE ( ) 980.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 13159

TODAY'S LOW / HIGH ( )959.85 1004.90

52 WK LOW / HIGH ( )955.2 1455.85

NSE1000.4011.2 (+1.13 %)

PREV CLOSE( ) 989.20

OPEN PRICE ( ) 977.65

BID PRICE (QTY) 1000.40 (41)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 313277

TODAY'S LOW / HIGH( ) 959.65 1004.90

52 WK LOW / HIGH ( )956 1456.5

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 13-08 2004

Management Info

Naresh Trehan - Chairman Naresh Trehan - Managing Director

Registered Office

Address Medanta- Mediclinic,E-18, Defence Colony,,
New Delhi,
Delhi-110024

Phone 011-44114411

Email info@medanta.org

Website www.medanta.org

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

05Feb Global Health informs about newspaper
Pursuant to Regulation 30 and 47 of the SEBI (Listing Obligations and Di..

28Nov Global Health launches 550 bed super s
Global Health (Medanta) has formally launched its new state-of-the-art 5..

27Nov Global Health informs about press rele
Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obliga..

11Nov Global Health submits analyst meet int
Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obliga..

04Oct Global Health informs about updates
Global Health has informed that it enclosed disclosure under Regulation..

Financials

Rs. in Millions

	QTR Dec 25	ANNUAL 25
Net Profit	799.070000000002	4615.28
Gross Profit	1028.86	6230.47
Operating Profit	1990.29	8559.45
Net Sales	9401.65	32041.46

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Kovai Medical Center (BSE) 5097.95 (0.82%)	M.Cap ( in Cr)5578.31
Kaya (BSE) 269.45 (8.65%)	M.Cap ( in Cr)409.23
Vijaya Diagnostic (BSE) 895.85 (1.40%)	M.Cap ( in Cr)8662.38
Apollo Hospital Ent. (BSE) 7316.35 (0.16%)	M.Cap ( in Cr)105197.89
Dr. Lal Pathlabs (BSE) 1329.30 (0.71%)	M.Cap ( in Cr)22273.09

Shareholding Pattern

	NON-INSTITUTION	42.46%
	PROMOTERS	33.01%
	MUTUAL FUNDS/UTI	13.12%
	FI/BANKS/INSURANCE	0.61%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Invesco India Focus...	3.74
Motilal Oswal Innov...	3.33
Invesco India Busin...	2.95
HSBC Consumption Fu...	2.74
PGIM India Healthca...	2.69
Invesco India Midca...	2.51
Invesco India Small...	2.42

Risk Disclosures on Derivatives

Smart Quotes

GLOBAL HEALTH LTD.